Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 4
2006 6
2007 5
2008 4
2009 3
2010 2
2011 4
2012 5
2013 1
2014 4
2015 5
2016 6
2017 4
2018 4
2019 8
2020 5
2021 7
2022 7
2023 8
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Kiladjian JJ, Marin FF, Al-Ali HK, Alvarez-Larrán A, Beggiato E, Bieniaszewska M, Breccia M, Buxhofer-Ausch V, Cerna O, Crisan AM, Danaila CD, De Stefano V, Döhner K, Empson V, Gora-Tybor J, Griesshammer M, Grosicki S, Guglielmelli P, García-Gutierrez V, Heidel FH, Illés A, Tomuleasa C, James C, Koschmieder S, Krauth MT, Krejcy K, Lazaroiu MC, Mayer J, Nagy ZG, Nicolini FE, Palandri F, Pappa V, Reiter AJ, Sacha T, Schlager S, Schmidt S, Terpos E, Unger M, Wölfler A, Cirici BX, Klade C. Kiladjian JJ, et al. Among authors: james c. Ann Hematol. 2024 Mar 4. doi: 10.1007/s00277-024-05665-4. Online ahead of print. Ann Hematol. 2024. PMID: 38438627
Circulating endothelial cells in pathophysiology.
Brett VE, Dignat George F, James C. Brett VE, et al. Among authors: james c. Curr Opin Hematol. 2024 May 1;31(3):148-154. doi: 10.1097/MOH.0000000000000814. Epub 2024 Feb 15. Curr Opin Hematol. 2024. PMID: 38362895 Review.
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
Galtier J, Drevon L, Le Bris Y, Giraudier S, Wemeau M, Legros L, Luque Paz D, Girodon F, Kiladjian JJ, Mesguich C, Parrens M, Mediavilla C, Roy L, Guy A, Mansier O, Ianotto JC, James C. Galtier J, et al. Among authors: james c. Haematologica. 2024 Feb 8. doi: 10.3324/haematol.2023.284488. Online ahead of print. Haematologica. 2024. PMID: 38328854 Free article.
Microrheology and structural quantification of hypercoagulable clots.
Wolff-Trombini L, Ceripa A, Moreau J, Galinat H, James C, Westbrook N, Allain JM. Wolff-Trombini L, et al. Among authors: james c. Biomed Opt Express. 2023 Jul 19;14(8):4179-4189. doi: 10.1364/BOE.492669. eCollection 2023 Aug 1. Biomed Opt Express. 2023. PMID: 37799698 Free PMC article.
Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
Guy A, Garcia G, Gourdou-Latyszenok V, Wolff-Trombini L, Josserand L, Kimmerlin Q, Favre S, Kilani B, Marty C, Boulaftali Y, Labrouche-Colomer S, Mansier O, James C. Guy A, et al. Among authors: james c. J Thromb Haemost. 2024 Jan;22(1):172-187. doi: 10.1016/j.jtha.2023.08.028. Epub 2023 Sep 9. J Thromb Haemost. 2024. PMID: 37678548
Genome-wide association study of a semicontinuous trait: illustration of the impact of the modeling strategy through the study of Neutrophil Extracellular Traps levels.
Munsch G, Proust C, Labrouche-Colomer S, Aïssi D, Boland A, Morange PE, Roche A, de Chaisemartin L, Harroche A, Olaso R, Deleuze JF, James C, Emmerich J, Smadja DM, Jacqmin-Gadda H, Trégouët DA. Munsch G, et al. Among authors: james c. NAR Genom Bioinform. 2023 Jun 28;5(2):lqad062. doi: 10.1093/nargab/lqad062. eCollection 2023 Jun. NAR Genom Bioinform. 2023. PMID: 37388819 Free PMC article.
92 results